ProTEC-USA Announces Expanded Medical Gown Manufacturing Capabilities

Cadillac Products, Inc.’s recent investment will allow the company to expand engineering, production and distribution from its Michigan facility, helping to meet the growing needs of medical gowns nationwide notes ProTEC-USA.

ProTEC-USA has announced the debut of a new, state of the art production work cell that will expand and enhance its capacity to produce EZDoff medical gowns for healthcare and other critical industries.

A subsidiary of Troy, Michigan-based Cadillac Products, Inc., in-house extrusion, film converting and gown manufacturing capabilities from the company’s facilities in the USA allow ProTEC-USA to serve as a strategic, domestic supply chain partner, delivering high-quality gowns with volume-level pricing.

“COVID-19 exacerbated market demands that were already growing prior to the pandemic,” said Don Lowe, Spokesperson, ProTEC-USA. “This investment from the company in upgrades and enhancements to production lines and equipment will boost our capacity in order to better meet demand.

The new, proprietary work cell was completely designed and built in–house, addressing all the needs for quality control and optimal cost. These gowns will be available in three color options—blue, yellow or white—and will also be available with level 1, 2 or 3 compliance, based on the depth of protective needs of the user.

“EZDoff gowns are designed to not only maintain effectiveness and mitigate potential self-contamination, but also to be mindful of the manner in which the gowns are donned and doffed in sequence with other PPE,” said Lowe. “Without touching the outside surface of the EZDoff gown to remove it, the wearer is protected against consequential contamination.”

EZDoff gowns offer several features and benefits for wearers, including:

– Perforated rear yoke for safe, easy doffing of medical gowns
– Sleeve with thumb loop for full arm and wrist protection, simultaneous glove donning
– Apron closure to maintain the user’s coolness during work performance
– Compliance with all AAMI and FDA specifications and requirements

More

Cofertility Closes Series A Funding, Led by Next Ventures and Offline Ventures, to Revolutionize Fertility and Family Building

April 16, 2025

The funding will be primarily used towards the further development of Cofertility’s proprietary, user-friendly technology platform, a custom-built egg donor database that streamlines the entire egg donation process, from recruitment and matching to cycle coordination. Already this technology has helped improve the Cofertility experience for its members.